|
|
Volumn 329, Issue 5988, 2010, Pages 154-155
|
|
Clearing Conformational Disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA 1 ANTITRYPSIN;
CARBAMAZEPINE;
CELL PROTEIN;
PROTEASOME;
MUTANT PROTEIN;
BIOCHEMISTRY;
CYTOPLASM;
DEGRADATION;
DISEASE CONTROL;
DISEASE TREATMENT;
DRUG;
MEDICINE;
MUTATION;
PHENOTYPE;
PROTEIN;
PUBLIC HEALTH;
TOXIC SUBSTANCE;
AUTOPHAGY;
CYTOPLASM;
ENDOPLASMIC RETICULUM;
HUMAN;
LIVER CELL;
LIVER FIBROSIS;
LIVER INJURY;
LOSS OF FUNCTION MUTATION;
LYSOSOME;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN FOLDING;
SHORT SURVEY;
TOXICITY;
ALPHA 1 ANTITRYPSIN DEFICIENCY;
ANIMAL;
CHEMISTRY;
DRUG EFFECT;
GENETICS;
LIVER CIRRHOSIS;
METABOLISM;
MOUSE;
NOTE;
PROTEIN CONFORMATION;
TRANSGENIC MOUSE;
ALPHA 1-ANTITRYPSIN;
ALPHA 1-ANTITRYPSIN DEFICIENCY;
ANIMALS;
AUTOPHAGY;
CARBAMAZEPINE;
HUMANS;
LIVER CIRRHOSIS;
MICE;
MICE, TRANSGENIC;
MUTANT PROTEINS;
PROTEASOME ENDOPEPTIDASE COMPLEX;
PROTEIN CONFORMATION;
PROTEIN FOLDING;
|
|
EID: 77954572292
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1192681 Document Type: Short Survey |
|
Times cited : (14)
|
|
References (12)
|
